Shelton Capital Management Lowered Merck & Co (MRK) Stake; Software AG (ETR:SOW) Had 5 Bullish Analysts

September 24, 2017 - By Winifred Garcia

Shelton Capital Management decreased Merck & Co Inc (MRK) stake by 8.18% reported in 2017Q2 SEC filing. Shelton Capital Management sold 4,705 shares as Merck & Co Inc (MRK)’s stock declined 2.46%. The Shelton Capital Management holds 52,810 shares with $3.39 million value, down from 57,515 last quarter. Merck & Co Inc now has $177.63 billion valuation. The stock decreased 0.72% or $0.47 on September 22, reaching $65.13. About 7.47M shares traded. Merck & Co., Inc. (NYSE:MRK) has risen 16.86% since September 24, 2016 and is uptrending. It has outperformed by 0.16% the S&P500.

Among 21 analysts covering Software (ETR:SOW), 5 have Buy rating, 4 Sell and 12 Hold. Therefore 24% are positive. Software has €40 highest and €23 lowest target. €33.52’s average target is -17.54% below currents €40.65 stock price. Software had 94 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was maintained by Kepler Cheuvreux on Wednesday, March 16 with “Hold”. The rating was upgraded by Baader Wertpapierhandelsbank on Thursday, July 14 to “Buy”. Oddo & Cie upgraded the stock to “Buy” rating in Friday, April 15 report. The stock of Software AG (ETR:SOW) earned “Underweight” rating by Morgan Stanley on Saturday, July 16. The stock of Software AG (ETR:SOW) earned “Underweight” rating by Barclays Capital on Wednesday, January 11. The rating was upgraded by Baader Wertpapierhandelsbank to “Buy” on Thursday, October 15. Barclays Capital downgraded it to “Underweight” rating and €31 target in Tuesday, October 18 report. Morgan Stanley downgraded Software AG (ETR:SOW) on Tuesday, January 31 to “Underweight” rating. The company was maintained on Friday, September 9 by HSBC. The firm has “Underweight” rating given on Saturday, October 15 by Morgan Stanley. See Software AG (ETR:SOW) latest ratings:

Investors sentiment increased to 1.07 in 2017 Q2. Its up 0.08, from 0.99 in 2017Q1. It is positive, as 56 investors sold MRK shares while 612 reduced holdings. 111 funds opened positions while 603 raised stakes. 1.95 billion shares or 0.77% less from 1.96 billion shares in 2017Q1 were reported. Boston Advsr Limited Liability Com has invested 0.55% in Merck & Co., Inc. (NYSE:MRK). Berkshire Asset Mngmt Ltd Liability Company Pa reported 188,161 shares. 139,708 were reported by Capwealth Lc. Georgia-based First City Cap Management has invested 1.59% in Merck & Co., Inc. (NYSE:MRK). The Ontario – Canada-based Bank & Trust Of Nova Scotia has invested 0.3% in Merck & Co., Inc. (NYSE:MRK). Moreno Evelyn V invested 0.74% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Jarislowsky Fraser Ltd reported 0.05% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Thomas J Herzfeld Advsrs Incorporated has invested 0.08% in Merck & Co., Inc. (NYSE:MRK). Markel accumulated 0.01% or 5,600 shares. 38,059 are owned by Pettee. Cutler Cap holds 0.22% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 7,000 shares. Cleararc Cap holds 61,963 shares. The United Kingdom-based Hermes Invest Mngmt Limited has invested 0.16% in Merck & Co., Inc. (NYSE:MRK). Profund Advisors Llc, Maryland-based fund reported 176,852 shares. Asset Mngmt Of Georgia Inc Ga Adv invested in 1.06% or 23,948 shares.

Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on October, 27 before the open. They expect $1.03 EPS, down 3.74% or $0.04 from last year’s $1.07 per share. MRK’s profit will be $2.81 billion for 15.81 P/E if the $1.03 EPS becomes a reality. After $1.01 actual EPS reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts 1.98% EPS growth.

Among 20 analysts covering Merck & Co. Inc. (NYSE:MRK), 15 have Buy rating, 1 Sell and 4 Hold. Therefore 75% are positive. Merck & Co. Inc. had 52 analyst reports since August 13, 2015 according to SRatingsIntel. Jefferies downgraded the shares of MRK in report on Monday, December 19 to “Underperform” rating. Guggenheim upgraded the shares of MRK in report on Thursday, January 12 to “Buy” rating. BMO Capital Markets maintained Merck & Co., Inc. (NYSE:MRK) rating on Monday, June 12. BMO Capital Markets has “Buy” rating and $7400 target. Credit Suisse maintained the stock with “Outperform” rating in Friday, September 8 report. BNP Paribas upgraded Merck & Co., Inc. (NYSE:MRK) on Tuesday, August 18 to “Outperform” rating. On Thursday, July 14 the stock rating was maintained by Jefferies with “Hold”. The firm earned “Buy” rating on Friday, August 4 by BMO Capital Markets. The firm has “Sell” rating given on Thursday, May 25 by Jefferies. The company was maintained on Wednesday, April 12 by Cowen & Co. The stock has “Buy” rating by BMO Capital Markets on Tuesday, June 6.

Shelton Capital Management increased Ares Cap Corp (NASDAQ:ARCC) stake by 26,000 shares to 93,141 valued at $1.53M in 2017Q2. It also upped General Electric Co (NYSE:GE) stake by 38,046 shares and now owns 265,706 shares. Morgan Stanley (NYSE:MS) was raised too.

The stock increased 0.81% or EUR 0.33 on September 22, reaching EUR 40.65. About 132,645 shares traded. Software AG (ETR:SOW) has 0.00% since September 24, 2016 and is . It has underperformed by 16.70% the S&P500.